As with all metazoans, the fly makes extensive use of selective programmed cell death (PCD) to remove excess cells and properly sculpt developing tissues. Several core components of the cell death machinery have been identified in flies, including caspases and an Apaf-1 ortholog [1-4]. One missing component has been a member of the Bcl-2 family of proteins, which act either pro-or anti-apoptotically as upstream regulatory proteins. Here, we report the identification of Bcl-2 family members in Drosophila -dBorg-1 (Drosophila Bcl-2 ortholog), also identified by Igaki et al.
We identified two Bcl-2 family members, dBorg-1 and dBorg-2, in Drosophila. Both proteins contain BH1, BH2 and BH3 domains and are most similar to Bok/Mtd, a proapoptotic family member [6, 7] (Figure 1a and see Supplementary material). Apart from an amino-terminal extension in dBorg-1, residues conserved within the Bcl-2 family are present throughout the length of the sequences and are concentrated in the BH domains. Recently, dBorg-1 (Drob-1) was also identified by Igaki et al. [5] , although Drob-1 was reported to contain additional amino acids at its amino terminus (see Materials and methods).
We observed by in situ analysis that both dborg-1 and dborg-2 are expressed between embryonic stages 11 and 16 ( Figure 1c ,f,g and Supplementary material), stages of maximal cell death [8] and dynamically throughout development of the fly (Figure 1b ) These results suggest a role in developmentally regulated cell death; however, the overall pattern of transcription does not distinguish between a pro-or anti-apoptotic function for these molecules. We therefore undertook a series of cell culture assays to investigate both possibilities.
Overexpression of dborg-1 promotes both death and survival in cell culture assays
Overexpression of dborg-1 in BHK.21, HEK 293, Chinese hamster ovary (CHO) and Drosophila Schneider S2 cells resulted in reduced viability (data not shown), indicating a strong conservation of killing function across species. A dose-response curve of the killing effect of dBorg-1 in CHO cells demonstrated the potency of this pro-apoptotic Bcl-2 family member: when 1 µg of the dborg-1 expression vector was used, 9% of the transfected cells were alive 48 hours later. Decreasing the amount of dborg-1 expression vector to 50 ng increased the survival rate to only 50% (Figure 2a ). Co-expression of the baculovirus caspase inhibitor p35 and dborg-1 in CHO cells indicated that the majority of cell killing by dBorg-1 is through a caspase-dependent mechanism (Figure 2b) . Surprisingly, Schneider S2 cells were relatively resistant to killing by dborg-1 expression, as transfections with less than 0.5 µg of dborg-1 expression vector did not appreciably kill S2 cells. We found that COS cells were also refractory to killing by dBorg-1. Perhaps these two cell types contain high levels of a protective Bcl-2 family member or do not normally express activators or cofactors required for the pro-apoptotic activity of dBorg-1. Our results confirm the finding by Igaki et al. [5] that dBorg-1 is a killer molecule in cell culture; however, we observed a greatly reduced potency of dBorg-1 killing in S2 cells. We speculate that the discrepancy between our results and those of Igaki et al. [5] might be due either to the method of dborg-1 expression or to the difference in the amino-termini of the expressed proteins (see Materials and methods).
As there is sequence similarity between dBorg-1 and the anti-apoptotic protein Bcl-2 ( Figure 1a and see Supplementary material), we examined the possibility that dBorg-1 might rescue cells from death. Following transfection of Drosophila S2 cells with an amount of dborg-1 expression plasmid that resulted in no appreciable cell killing, we induced apoptosis in two ways. First, by expressing the Caenorhabditis elegans caspase CED-3 and second, by serum deprivation. In both cases we consistently observed a significant increase in the number of viable cells after 24 hours (Figure 2c ), demonstrating that this pro-apoptotic protein can also act as a pro-survival molecule. Such a functional conversion of a Bcl-2 family member has been described previously -Bcl-2 becomes a killer molecule upon cleavage [9] . Similarly, it is possible that a post-translational modification could turn dBorg-1 into a protective molecule. Alternatively, overexpression of dborg-1 might lead to the up-regulation of a protective pathway in S2 cells, resulting in resistance to apoptosis.
RNA-mediated interference of dborg-1 results in excess glial cells
We used an RNA interference assay (RNAi) to mimic loss of dborg-1 function and to inactivate the maternal contribution of dborg-1 mRNA. We injected double-stranded dborg-1 RNA (dsRNA) into the posterior pole region of pre-cellular blastoderm embryos. TUNEL analysis of stage 12/13 embryos injected with dborg-1 dsRNA (Figure 1h ) showed a reduction in TUNEL-positive cells compared with a wildtype embryo (Figure 1i ), indicating that developmental PCD was inhibited. To further assess the development of embryos injected with dborg-1 dsRNA, we analyzed stage 16 embryos with an antibody to a glial-specific marker. We observed a dramatic expansion of glial cells into the posterior region near the site of injection in 44% of the dborg-1 dsRNA-injected embryos (n = 32; Figure 1j ). This phenotype was never observed in control embryos injected with white dsRNA (Figure 1k) . Thus, reduction of dBorg-1 activity led to ectopic cells at the site of injection, including a large number of glia, suggesting that this excess tissue was contiguous with the central nervous system (CNS). Fusion of the most posterior embryonic segments, A8 and A9, requires PCD and aids contraction of the CNS [8, 10] . Inhibition of PCD may have resulted in A8 and A9 remaining distinct, leading to an extended CNS region wrapped around excess posterior tissue. Alternatively, excess glial cells may be a response to injection trauma and dBorg-1 might be required not only for normal developmental apoptosis, but also to remove these glial cells.
UV-irradiation potentiates dBorg-1-induced death in the eye
To further assess the in vivo role of dBorg-1, we created GMR-dborg-1 transgenic flies that express dborg-1 exclusively in the developing retina. None of the independent transgenic lines exhibited the expected ablated eye phenotype seen upon overexpression of other death-inducers such as reaper or grim [8] ; however, occasional interommatidial pigment cells were missing and bristle groups were mispositioned, suggesting a failure in the correct regulation of interommatidial cell position or removal (data not shown). Igaki et al. [5] also demonstrate a phenotype due to ectopic expression of dborg-1 in the eye that is ascribed to an increase in cell death.
The subtle phenotype of the GMR-dborg-1 flies suggested that simple overexpression of dborg-1 was insufficient to kill and raised the possibility that dBorg-1 requires appropriate activation before inducing apoptosis in vivo, an idea consistent with the broad expression of dborg-1 in embryonic tissues. One candidate activator is the DNA damage response pathway. We used UV irradiation to determine the ability of DNA damage to potentiate dBorg-1 function. High levels of irradiation (50,000 µJ/cm 2 ) resulted in a nearly ablated eye. Lower doses (20,000 µJ/cm 2 ) resulted in only minor loss of cells (Figure 3a) . Concomitant expression of dborg-1 resulted in dramatically enhanced cell killing and a severely reduced eye; this phenotype was partially rescued by co-expression of the baculovirus protein p35, an inhibitor of caspase function. These results indicate a strong synergy between death induced by dBorg-1 and the DNA damage response pathway.
The potentiation of UV-irradiation-induced death by ectopically expressed dborg-1 suggests that the killer function of dBorg-1 is post-transcriptionally regulated. Previous work in cell culture has led to the idea that the balance of pro-and anti-apoptotic Bcl-2 family members is critical for determining whether a cell is permitted to survive [11] . Therefore, a vast excess of an as yet unknown, anti-apoptotic Bcl-2 family member in the developing eye could, by hetero-dimerization, neutralize the dBorg-1 pro-apoptotic function (as observed for Bax with Bcl-2 [12] ). Alternatively, dBorg-1 may require additional post-translational modifications to be fully activated that are not provided during the normal development of the fly eye. By analogy with known Bcl-2 family members, this could be through conformational change (as observed for Bax [13, 14] ), cleavage (as described for Bcl-2 [9] ) or by phosphorylation (as is the case for Bad [15] ).
There are many unresolved questions regarding the regulation of Bcl-2 family members and their true in vivo Brief Communication 549 function. Our ability to study the Bcl-2 family in Drosophila provides an important new tool for the elucidation of this critical apoptotic pathway. Furthermore, our observation that the pro-apoptotic activity of dBorg-1 dramatically increased following UV-irradiation provides new strategies to dissect the apoptotic response to DNA damage, both genetically and biochemically.
While this manuscript was in review, these Drosophila Bcl-2 orthologs were described [16] .
Materials and methods

Identification and sequencing of dborg-1 cDNA
We identified a cDNA encoding dborg-1 through its homology with Bcl-2. A 3′ EST from GH01265 contained the homology and overlapped at the 5′ end with two other cDNAs, GH01665 and LD12719. All three cDNAs have identical putative coding regions except for a 2 bp deletion within the ORF in GH01265 and GH01665 (resulting in a frameshift removing the BH2 domain). Sequencing of the genomic DNA encoding dborg-1 by the Berkeley Drosophila Genome Project (GenBank AC007624 and AC007593) showed that the 2 bp deletion is within an exon and not coded for by the genomic DNA. The predicted open reading frame (ORF) is 903 bp long, and all three cDNAs share identical 5′ and 3′ UTR sequences. An additional 25 amino-terminal amino acids are reported by Igaki et al. [5] ; however, we found no evidence for this extension in the genomic DNA or the cDNA sequences. The gene encoding dBorg-2 was identified by sequence homology with Bcl-2 and dBorg-1. This is encoded on a sequenced, but as yet unordered BAC (accession number AC007473). Most or all of the gene is encoded on one clone from the BAC, allowing us to run FGENESH (http://genomic.sanger.ac.uk/gf/gf.html) to create the ORF sequence. We modified this sequence on the basis of sequence homology with dBorg-1. The dborg-1 sequence has been deposited in GenBank under accession number AF244352.
Supplementary material
Additional detailed methods, in situ analyses and a protein alignment are available at http://current-biology.com/supmat/supmatin.htm.
Figure 3
Cell death mediated by dBorg-1 is potentiated by UV-irradiation, an effect that is rescued by p35. In all experiments, 23 h pupae were irradiated on their sides on the same slide with 20,000 µJ/cm 2 using a Stratalinker (Stratagene).
